Orthopaedic Institute of Western Kentucky PLLC

Orthopaedic Institute of Western Kentucky PLLC was paid $1.03M by Medicaid between Mar 2022 and Sep 2024, across 37 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 31% of everything it billed.

33Billing provider infoORTHOPAEDIC INSTITUTE OF WESTERN KENTUCKY PLLC
PADUCAH, KY 42001

33aNPI1497425177assigned 09/15/2021

33bProvider typePhysician Assistant

28Total paid$1.03M

24GClaims40,499

24DCodes billed37

24AFirst – last monthMar 2022 – Sep 2024

Compared with peers

Next to other Physician Assistant providers in Kentucky

Rank by total paid#51 of 214

Median peer was paid$134K

This provider vs. median7.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2022	17,263	$442K
2023	17,577	$455K
2024incomplete	5,659	$135K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	31%	13,886	12,131	$323K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	20%	9,312	2,617	$205K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	7.4%	1,577	1,468	$77K
20610		5.5%	1,978	1,659	$57K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	5.5%	1,542	1,402	$57K
62323		3.2%	265	229	$33K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	3.0%	432	382	$31K
L4361	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf	2.5%	140	133	$26K
72110		2.4%	1,149	1,047	$24K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	2.3%	681	449	$23K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	2.3%	91	84	$23K
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	2.2%	583	464	$23K

25 more codes

73630		2.2%	1,618	$22K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	1.9%	86	$20K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	1.7%	1,284	$18K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	1.1%	1,049	$12K
73564		<1%	650	$9K
99215	Doctor's office visit, returning patient (complex)	<1%	132	$7K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	370	$7K
72050		<1%	273	$6K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	415	$5K
97161		<1%	130	$5K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	1,081	$4K
73130		<1%	237	$3K
73502		<1%	143	$2K
73610		<1%	164	$2K
73110		<1%	145	$2K
97014		<1%	290	$1K
73030		<1%	96	$1K
99406		<1%	82	$638.64
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	41	$603.79
97162		<1%	15	$550.26
73140		<1%	39	$406.48
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	445	$349.96
97022		<1%	27	$235.98
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	37	$63.49
99024		0%	14	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKERN, BRIAN (PRESIDENT)